StockGlow

Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences, Inc.

$43.37+0.05%Healthcare
Compare SPRB with
StockGlow Score
51
Neutral
BearishBullish
1 year ago-92.9%

The outlook

Spruce Biosciences, Inc. currently reads as neutral based on strong buy — 1.1 avg of 8 analysts, below its 50- & 200-day averages, 5% of the way from its 52-week low to high, avg target +248% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusStrong Buy — 1.1 avg of 8 analysts
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +248% vs current price

Analyst price target

~12-month · 8 analysts
$151.00average target+248.2% vs now
Now $43.37
Low $120.00High $230.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$119.4M
52-wk high
$675.00
52-wk low
$7.00
50-day avg
$49.15
200-day avg
$73.31
Trailing P/E
—

Similar stocks

DMRADamora Therapeutics, Inc.$29.21+3.11%ABVXABIVAX Société Anonyme$124.33+4.62%ONMDOneMedNet Corporation$0.73+13.31%CWDCaliberCos Inc.$0.51+1.45%QMMMQMMM Holdings Limited$119.40+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy